Results 161 to 170 of about 15,419 (219)

Eight Years of Canadian Real-World Assessment of Tolvaptan in Patients With Autosomal Dominant Polycystic Kidney Disease: The C-MAJOR Registry. [PDF]

Can J Kidney Health Dis
McFarlane P, Bichet DG, Alam A, Bubolic S, Laplante A.   +4 more
europepmc   +1 more source

Cervical Artery Dissection in Autosomal Dominant Polycystic Kidney Disease. [PDF]

Medicina (Kaunas)
Liu A, Xeros H, Wahood W, Keser Z, Khan M.   +4 more
europepmc   +1 more source

A case of autosomal dominant polycystic kidney disease with multiple bilateral spontaneous retroperitoneal hemorrhages. [PDF]

CEN Case Rep
Mizuta M, Suwabe T, Oba Y, Sekine A, Yamanouchi M, Mizuno H, Hasegawa E, Wada T, Fukuda M, Miyazono M, Sawa N, Ubara Y.   +11 more
europepmc   +1 more source

Impact of visceral adipose tissue on eGFR slope in early ADPKD: evidence from a real-world cohort. [PDF]

Clin Kidney J
Capelli I, Sanfilippo I, Valeri L, Vetrano D, Lorenzini G, Sciascia N, Aiello V, Lerario S, Ciurli F, La Manna G, Corsi C.   +10 more
europepmc   +1 more source

Machine Learning Prediction of Progression to Dialysis in Patients With Polycystic Kidney Disease: Population-Based Retrospective Cohort Study.

JMIR Med Inform
Chang CH, Chen M, Tsai MH, Huang YC, Liou HH, Shia BC, Liang C, Fang YW.   +7 more
europepmc   +1 more source

Clinical and Genetic Characterization of a Patient With SEC63-Related Autosomal Dominant Polycystic Liver Disease and an IFT140 Pathogenic Variant Associated With Polycystic Kidney Disease. [PDF]

Cureus
Ortega-Macías AG, Gupta U, Escobar Gil T, Memon J, García PR.   +4 more
europepmc   +1 more source

Cardiovascular Complications in ADPKD

Kidney International Reports
Ebrahimi, Niloufar, Caliskan, Yasar, Garimella, Pranav S., Carriazo, Sol, Chebib, Fouad T., Bateni, Giv Heidari, Dahl, Neera K., Rastogi, Anjay, Abdipour, Amir, Norouzi, Sayna   +9 more
openaire   +2 more sources

Real-world outcomes of managing autosomal-dominant polycystic kidney disease using a medical food as part of a nutrition and lifestyle program to improve renal and metabolic health. [PDF]

Front Nutr
Muensterman E, Torres JA, Weimbs T.
europepmc   +1 more source

Typical and atypical ADPKD: predicted pathogenic genetic variants and population frequencies. [PDF]

Nephrol Dial Transplant
Varughese S, Huang M, Savige J.
europepmc   +1 more source

Feasibility Study of Empagliflozin in Patients with Autosomal Dominant Polycystic Kidney Disease: Design and Baseline Characteristics. [PDF]

Am J Nephrol
Seliger SL, Wang W, Watnick T, George D, Diggs C, West M, Nowak K, Ostrow A, You Z, Gitomer B, Chonchol M.   +10 more
europepmc   +1 more source